DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Healthcare
Updated 1m ago
OTC logo

Ocumetics Technology Corp.TSXV:OTC Stock Report

Market Cap CA$64.9m
Updated 1m ago
Share Price
n/a
1Y-62.7%
7D3.4%
1D-3.2%
Portfolio Value
​
View

Ocumetics Technology Corp.

TSXV:OTC Stock Report

Market Cap: CA$64.9m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Ocumetics Technology (OTC) Stock Overview

Engages in research, development, production, and sale of vision enhancement products in Canada. More details

OTC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Makes less than USD$1m in revenue (CA$0)

Earnings have declined by 25.8% per year over past 5 years

Negative shareholders equity

Does not have a meaningful market cap (CA$65M)


OTC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW431,284 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
431,284 investors already sharing narratives
CA$
Current Price
CA$0.46n/aintrinsic discount
Est. Revenue
$
PastFuture-8m12016201920222025202620282031Revenue CA$1.0Earnings CA$0.1
Advanced
View all narratives

Ocumetics Technology Corp. Competitors

Zentek

Symbol: TSXV:ZEN
Market cap: CA$96.2m

Theralase Technologies

Symbol: TSXV:TLT
Market cap: CA$57.4m

Perimeter Medical Imaging AI

Symbol: TSXV:PINK
Market cap: CA$43.7m

Cheelcare

Symbol: TSXV:CHER
Market cap: CA$32.7m

Price History & Performance

Summary of share price highs, lows and changes for Ocumetics Technology
Historical stock prices
Current Share PriceCA$0.46
52 Week HighCA$1.40
52 Week LowCA$0.35
Beta0.33
1 Month Change12.35%
3 Month Change-17.27%
1 Year Change-62.70%
3 Year Change42.19%
5 Year Change8.33%
Change since IPO-21.55%

Recent News & Updates

Recent updates

Analysis Article • Aug 05

We Think Ocumetics Technology (CVE:OTC) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Shareholder Returns

OTCCA Medical EquipmentCA Market
7D3.4%0.7%0.2%
1Y-62.7%-1.9%20.9%

Return vs Industry: OTC underperformed the Canadian Medical Equipment industry which returned -1.3% over the past year.

Return vs Market: OTC underperformed the Canadian Market which returned 21.5% over the past year.

Price Volatility

Is OTC's price volatile compared to industry and market?
OTC volatility
OTC Average Weekly Movement9.8%
Medical Equipment Industry Average Movement12.1%
Market Average Movement9.1%
10% most volatile stocks in CA Market16.0%
10% least volatile stocks in CA Market3.6%

Stable Share Price: OTC has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatility Over Time: OTC's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/aDean Burnsocumetics.com

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd.

Ocumetics Technology Corp. Fundamentals Summary

How do Ocumetics Technology's earnings and revenue compare to its market cap?
OTC fundamental statistics
Market capCA$64.88m
Earnings (TTM)-CA$7.57m
Revenue (TTM)n/a
0.0x
P/S Ratio
-8.6x
P/E Ratio

Is OTC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OTC income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$7.57m
Earnings-CA$7.57m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.053
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-98.2%

How did OTC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 09:17
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ocumetics Technology Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide